Found 8 matching trials
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
PHASE2This is a Phase 2, double-blind, placebo-controlled study to determine the ...
Location
The Indiana Clinical Trials Center,PC
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
PHASE3This is a Phase 3, double-blind, randomized, vehicle-controlled study (Stud...
Location
Florida Center for Dermatology, P.A.
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
PHASE3This is a Phase 3, double-blind, randomized, vehicle-controlled study (Stud...
Location
DelRicht Research
Cantharidin Application in Molluscum Patients-1
PHASE3This study is a Phase 3, randomized, double-blind, placebo-controlled, pivo...
Location
Alabama Clinical Therapeutics
Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.
PHASE2The primary objective of the study is to determine the presence or absence ...
Location
Midwest Children's Health
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
PHASE3People who participated in either the COVE-2 or COVE-3 study for common war...
Location
Florida Center for Dermatology, P.A.
Cantharidin and Occlusion in Verruca Epithelium
PHASE2This is a Phase 2, open label study (Study number VP-102-105; referred to a...
Location
Cohort 2: Applied Research Center of Arkansas
Cantharidin Application in Molluscum Patients
PHASE3This study is a Phase 3, randomized, double-blind, placebo-controlled, pivo...
Location
Bakersfield Dermatology